NCT03756662View on ClinicalTrials.gov

Performance and Safety of the ARGOS-SC Suprachoroidal Pressure Sensor in Patients With Glaucoma Undergoing Non-penetrating Glaucoma Surgery

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 19, 2018

Primary Completion Date

February 18, 2021

Study Completion Date

February 18, 2021

Conditions
GlaucomaOpen Angle Glaucoma
Interventions
DEVICE

ARGOS-SC suprachoroidal pressure sensor

The sensor device is intended to be permanently implanted suprachoroidal in the human eye during non-penetrating glaucoma surgery.

Trial Locations (5)

1006

Swiss Glaucoma Research Foundation, Centre du Glaucome, Clinique Montchoisi, Lausanne

44892

Universitäts-Augenklinik, Bochum

55131

Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Augenklinik und Poliklinik, Mainz

66280

Knappschaftsklinikum Saar GmbH, Augenklinik Sulzbach, Sulzbach

80336

Augenklinik der LMU München, München

All Listed Sponsors
collaborator

CRO Dr. med Kottmann GmbH & Co. KG

INDUSTRY

lead

Implandata Ophthalmic Products GmbH

INDUSTRY

NCT03756662 - Performance and Safety of the ARGOS-SC Suprachoroidal Pressure Sensor in Patients With Glaucoma Undergoing Non-penetrating Glaucoma Surgery | Biotech Hunter | Biotech Hunter